If you have been reading about lyophilisation and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-01-09. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
| Property | Value | Notes |
|---|---|---|
| Name type | Commercial trade name | Not a systematic chemical identifier |
| Parent peptide | Thymosin beta-4 | 43-residue natural peptide |
| Common fragment sequence | LKKTETQ | Maps to part of the actin-binding region |
| Molecular size class | Roughly 0.8-1.0 kDa | Depends on exact fragment and terminal modification |
| Regulatory status | Prohibited in sport | Grouped with peptide hormones in many frameworks |
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
West of the Porte Palatine stands the Quadrilatero Romano (Roman Quadrilateral), the old medieval district recently renewed. The current neighbourhood is characterised by its tiny streets and its several medieval buildings and today it is popular for its aperitivo bars and its small shops run by local artisans. The hub of the Quadrilatero is Piazza Emanuele Filiberto. South of the Quadrilatero Romano stands Via Garibaldi, another popular street of the city. It is a 1 km (0.6 mi) pedestrian street between Piazza Castello and Piazza Statuto which features some of the old shops of the city. Large Piazza Statuto is another example of Baroque square with arcades. Another main street of downtown is Via Pietro Micca, which starts in Piazza Castello and ends in the large Piazza Solferino. The street continues in Via Cernaia up to Piazza XVIII Dicembre, which features the former Porta Susa passengers building, relocated in 2012 a little more southward. The new and larger passengers building is situated between Corso Bolzano and Corso Inghilterra and is an example of contemporary architecture, being a 300 m-long (980 ft) and 19 m-high (62 ft) glass and steel structure. Porta Susa is currently the international central station of the city (high speed trains to Paris) and it is becoming the central hub of railway transportation of the city, being the station in which local trains (so-called Ferrovie Metropolitane), national trains and high-speed national and international trains converge. Close to Via Cernaia stands the Cittadella (Citadel), in the Andrea Guglielminetti garden.
== Gaiden 1 == The Gaiden 1 (外伝1) series, released between February and September 1998, adapts the short stories "Silver-White Valley" (episodes 1–4), "Dreams of the Morning, Songs of the Night" (5–8), "Dishonour", and the novel A Hundred Billion Stars, a Hundred Billion Lights (9–12). Both Gaidens are prequels to the main story, depicting events that take place before season 1 of the show.
== Histatin 5 == Histatin 5 is the protein that is associated with the most antifungal function. The antimicrobial activity is concentrated in a region known as the functional domain. An example of its antimicrobial activity is its mechanism of action against C. albicans. The peptide is consumed by the cell and it causes ATP efflux and the production of reactive oxygen species.
Sources: en.wikipedia.org
In ancient India, various teachings about well-being are found in the Hindu tradition, formulated in the first two millennia BCE in the Vedas, Upanishads, and the Smriti literature. They include the ideas that a person should fulfill their duty relative to their social role and stage of life, and that one should attain knowledge about how the self and the world are ultimately one. A central element of the Buddhist conception of well-being is the avoidance of suffering. The Buddha (roughly 6th century BCE) identified craving as the root cause of suffering, proposing a set of practical recommendations, such as right conduct and mindfulness, to overcome it. In ancient China, Confucius (6th to 5th century BCE) emphasized the role of social virtues in leading a good life, with a particular focus on benevolence or humaneness. In the Taoist tradition, Laozi (6th century BCE) saw living in harmony with the natural order of the universe through effortless, spontaneous action as the ideal form of life. During the medieval period in the West, Christian thinkers associated well-being with spiritual salvation. Augustine (354–430 CE) argued that humans are not fully in control of their well-being and instead depend on divine grace. He maintained that true happiness is achievable only in the afterlife. Thomas Aquinas (1225–1274 CE) similarly emphasized the role of the divine, proposing that a beatific vision of God is the highest form of well-being.
Burials may be placed in a number of different positions. Bodies with the arms crossed date back to ancient cultures such as Chaldea in the 10th century BC, where the "X" symbolized their sky god. Later ancient Egyptian gods and royalty, from approximately 3500 B.C. are shown with crossed arms, such as the god Osiris, the Lord of the Dead, or mummified royalty with crossed arms in high and low body positions, depending upon the dynasty. The burial of bodies in the extended position refers to lying flat with arms and legs straight, or with the arms folded upon the chest, and with the eyes and mouth closed. Extended burials may be supine (lying on the back) or prone (lying on the front). However, in some cultures, being buried face down shows marked disrespect, like in the case of the Sioux. Other ritual practices place the body in a flexed position with the legs bent or crouched with the legs folded up to the chest. Warriors in some ancient societies were buried in an upright position. In Islam, the body is placed in supine position, hands along the sides and the head is turned to its right with the face towards the Qibla. Many cultures treat placement of dead people in an appropriate position to be a sign of respect even when burial is impossible. In nonstandard burial practices, such as mass burial, the body may be positioned arbitrarily. This can be a sign of disrespect to the deceased, or at least nonchalance on the part of the inhumer, or due to considerations of time and space.
The cyanogenic glycosides in some white clover (Trifolium repens) varieties may influence the Se requirement, presumably because of cyanide from the aglycone released by glucosidase activity in the rumen and inactivation of glutathione peroxidases by the effect of absorbed cyanide on the glutathione moiety. In areas where selenium deficiency in livestock is a concern, selenium (as selenite) may be supplemented in feed. Certain countries, e.g., the US and Canada, regulate such supplementation. Neonate ruminants at risk of WMD may be administered both Se and vitamin E by injection; some of the WMD myopathies respond only to Se, some only to vitamin E, and some to either.
Sources: en.wikipedia.org
=== Homoleptic complexes (only amino acid ligands) === Mixing simple metal salts with solutions of amino acids near neutral or elevated pH often affords bis- or tris complexes. For metal ions that prefer octahedral coordination, these complexes often adopt the stoichiometry M(aa)3 (aa = amino carboxylate, such as glycinate, H2NCH2CO2−). Complexes of the 3:1 stoichiometry have the formula [M(O2CC(R)HNH2)3]z. Such complexes adopt octahedral coordination geometry. These complexes can exist in facial and meridional isomers, both of which are chiral. The stereochemical possibilities increase when the amino acid ligands are not homochiral. Both the violet meridional and red-pink facial isomers of tris(glycinato)cobalt(III) have been characterized With L-alanine, L-leucine, and other amino acids, one obtains four stereoisomers. With cysteine, the amino acid binds through N and thiolate. Complexes with the 2:1 stoichiometry are illustrated by copper(II) glycinate [Cu(O2CC(R)HNH2)2], which akso exists as a pentacoordinate monohydrate. When the metal is square planar, these complexes can exist as cis and trans isomers. The stereochemical possibilities increase when the amino acid ligands are not homochiral. Homoleptic complexes are also known where the amino carboxylate is tridentate amino acids. One such complex is Ni(κ3-histidinate)2.
Mendeleev, reading de Boisbaudran's publication, sent a letter claiming that gallium was his predicted eka-aluminium. Although Lecoq de Boisbaudran was initially sceptical, and suspected that Mendeleev was trying to take credit for his discovery, he later admitted that Mendeleev was correct. In 1879, the Swedish chemist Lars Fredrik Nilson discovered a new element, which he named scandium: it turned out to be eka-boron. Eka-silicon was found in 1886 by German chemist Clemens Winkler, who named it germanium. The properties of gallium, scandium, and germanium matched what Mendeleev had predicted. In 1889, Mendeleev noted at the Faraday Lecture to the Royal Institution in London that he had not expected to live long enough "to mention their discovery to the Chemical Society of Great Britain as a confirmation of the exactitude and generality of the periodic law". Even the discovery of the noble gases at the close of the 19th century, which Mendeleev had not predicted, fitted neatly into his scheme as an eighth main group. Mendeleev nevertheless had some trouble fitting the known lanthanides into his scheme, as they did not exhibit the periodic change in valencies that the other elements did. After much investigation, the Czech chemist Bohuslav Brauner suggested in 1902 that the lanthanides could all be placed together in one group on the periodic table.
During the early 20th century, the Russian movement of Cosmism, as represented by Nikolai Fyodorovich Fyodorov, envisioned scientific resurrection of dead people. The idea was so popular that, after Vladimir Lenin's death, Leonid Krasin and Alexander Bogdanov suggested to cryonically preserve his body and brain in order to revive him in the future. Necessary equipment was purchased abroad, but for a variety of reasons the plan was not realized. Instead his body was embalmed and placed on permanent exhibition in the Lenin Mausoleum in Moscow, where it is displayed to this day. The mausoleum itself was modeled by Alexey Shchusev on the Pyramid of Djoser and the Tomb of Cyrus.
== Works == Newsom, Gavin; Dickey, Lisa (February 7, 2013). Citizenville: How to Take the Town Square Digital and Reinvent Government. Penguin. ISBN 978-1101605813. Newsom, Gavin (February 24, 2026). Young Man in a Hurry: A Memoir of Discovery. Penguin. ISBN 978-1984881939.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.
Published work usually examines actin binding, cell migration and tissue repair endpoints in cell and animal models. Findings are generally described as preliminary, and controlled human data remain limited.
Because TB-500 is a trade name rather than a chemical identifier, different vendors and papers may attach it to different fragment lengths. Checking the stated sequence is the practical way to resolve the ambiguity.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.